$1.94
0.042.11%
At close: -
$1.92
-0.02-1.03%
After Hours: 6:59 AM EDT
Lexaria Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lexaria Bioscience using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-01-10 | $-0.16 | $-0.12 | -33.3 % |
Q4 | 2024-11-26 | $-0.15 | $-0.11 | -36.4 % |
Q3 | 2024-07-12 | $-0.13 | $-0.10 | -30.0 % |
Q2 | 2024-04-09 | $-0.06 | $-0.10 | 40.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2025-01-10 | $183.92K | $100.00K | 83.9 % |
Q4 | 2024-11-26 | $84.00K | $150.00K | -44.0 % |
Q3 | 2024-07-12 | $84.00K | $150.00K | -44.0 % |
Q4 | 2023-11-20 | $0 | $170.00K | -100.0 % |
Lexaria Bioscience (LEXX) is scheduled to report earnings on April 8, 2025. The last reported earnings were for reported on January 10, 2025 for Q1.
The Actual EPS was $-0.16, which missed the estimate of $-0.12.
The Actual Revenue was $183.9K, which beat the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.